Last reviewed · How we verify
NCT03693911: AcceptME
ACT to Prevent Eating Disorders: Evaluating a Gamified Prevention Program
NA trial testing Acceptance and Commitment Therapy in High Risk for Eating Disorder in 92 participants. Status unknown.
5 May 2018
Quick facts
| Lead sponsor | University of Cyprus |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 92 |
| Start date | 14 January 2016 |
| Primary completion | 5 May 2018 |
| Estimated completion | 30 January 2019 |
| Sites | 1 location across Cyprus |
Drugs / interventions tested
- Acceptance and Commitment Therapy
Conditions studied
- High Risk for Eating Disorder — all drugs for High Risk for Eating Disorder →
- Eating Disorders in Adolescence — all drugs for Eating Disorders in Adolescence →
- Acceptance Processes — all drugs for Acceptance Processes →
Sponsor
University of Cyprus
Who can join
Adults 13 to 25, female only, with High Risk for Eating Disorder or Eating Disorders in Adolescence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Eating Disorders (ED) constitute a serious public health issue that affects predominantly women and appears typically in adolescence or early adulthood. ED are extremely difficult to treat as these disorders are ego-syntonic and many patients do not seek treatment. As ED are associated with significant adverse medical and psychological consequences, it is vital to focus on the development of successful prevention programs. Even though, in the last two decades significant steps have been made over the development of efficacious and effective ED prevention programs, there is room for improvement in regards to effect sizes. Prevention programs for ED to date have focussed on either reducing the pursuit of the thin ideal or on disputing and replacing unrealistic thoughts with regard to food, body and weigh. There is a growing body of evidence supporting the functional relationship between ED symptomatology and control of emotional states either by avoiding or inhibiting emotional responses. The present study aimed to investigate the effectiveness and acceptability of a digital Acceptance and Commitment Therapy (ACT) based prevention program in comparison to a wait-list control group for young women identified to be at risk for ED. The goals of the study were to describe the development of the AcceptME protocol and digitalized program, assess participants' feedback and the acceptability of the program, and examine the effectiveness of the ACT-based prevention program compared to a wait-list control group. This prevention program has several innovations: a) it is based on ACT theory and practices; b) it uses gamification principles to create a program appealing to adolescents; c) it targets behaviour change in individuals via helping a digital character overcome difficulties in the digitalized program.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Randomized Clinical Trial Evaluating <i>AcceptME</i>-A Digital Gamified Acceptance and Commitment Early Intervention Program for Individuals at High Risk for Eating Disorders.
Karekla M, Nikolaou P, Merwin RM. · · 2022 · cited 13× · PMID 35407386 · DOI 10.3390/jcm11071775
Verify or expand the search:
- PubMed search for NCT03693911
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Acceptance and Commitment Therapy
Trials testing the same drug.
- NCT07397195 — ACT for Veterans With IBD and Mental Health Challenges · NA · not yet recruiting
- NCT07345806 — A Pilot Study on an ACT-Based Program for Individuals With Special Needs and Their Caregivers · NA · recruiting
- NCT07512388 — Acceptance and Commitment Therapy for Post-Stroke Adjustment Via Telerehabilitation · NA · active not recruiting
- NCT06647589 — Acceptance and Commitment Therapy for Religious OCD · NA · recruiting
- NCT06971861 — Just ACT for Student Well-being · NA · recruiting
Other University of Cyprus trials
Trials by the same sponsor.
- NCT07504185 — Physiotherapy After Emergency Laparotomy in the Elderly · NA · recruiting
- NCT06517706 — Brain Research and Integrative Neuroscience Network for COVID-19 · NA · recruiting
- NCT06471387 — Unraveling the Genetic Basis of Nicotine Addiction for Novel Therapeutic Strategies · recruiting
- NCT05746234 — Emotion Regulation For All (ER4ALL) Study · NA · unknown
- NCT05218031 — Acceptance and Commitment Group Therapy for Unaccompanied Minors · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03693911 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Cyprus
- Last refreshed: 3 October 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03693911.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing